The following sections of the instructions for medical use of the drug have been amended;
— «Side Effects.» — The information has been updated. Information was added to subsection: «Skin and subcutaneous tissue disorders»: acute generalized exanthematous pustulosis and drug rash with eosinophilia and systemic symptoms (DRESS syndrome) with an incidence of «very rare».
